News & Updates

Patients with coronavirus disease-2019 (COVID-19) commonly present with headaches, loss of smell and taste, diarrhea, and breathing difficulties.

Patients with breast or gastrointestinal (GI) cancer who are being treated with capecitabine monotherapy may benefit from using topical diclofenac gel to prevent or reduce the incidence of hand-foot syndrome (HFS), a common side effect of some chemotherapy drugs, reports a recent study presented at ESMO 2023.

Use of ivarmacitinib 4- and 8-mg doses for 24 weeks eases hair loss and is generally tolerated in patients with moderate or severe alopecia areata (AA), a phase II study has shown.

Histologic margin status shows a robust association with progression for lentigo maligna melanoma, suggest the results of a recent study.